The peptide supplier market has a transparency problem.
Over 75 firms claim peptide API manufacturing capabilities. The real number with verified commercial-scale capacity is far smaller. Hundreds more operate as resellers, drop-shippers, and gray-market vendors with little visibility into their supply chain.
This directory cuts through that noise. We track 310 suppliers across 20+ countries with confidence scores, verification badges, and sourcing notes on each.
Not All Suppliers Are Created Equal
The first question to answer: what kind of supplier do you actually need?
Manufacturers physically synthesize peptides. We list 183 companies flagged as in-house producers. Only 82 hold verifiable GMP certification. If the supplier cannot prove they make the product themselves, assume they are reselling.
Browse manufacturers →
CDMOs handle custom synthesis and scale-up. We list 101. Fewer than 15 worldwide have commercial-scale GLP-1 capacity as of mid-2026. That bottleneck gives them enormous pricing power.
Browse CDMOs →
Research suppliers sell for research use only (RUO). We list 113. Of those, 162 of our total 310 suppliers have third-party testing verification and 187 provide batch-specific COAs. The rest may not.
Browse research suppliers →
Wholesale and bulk suppliers distribute larger quantities, often with private labeling. We list 37. If you are starting a distribution business, this is your category.
Browse wholesale suppliers →
Compounding pharmacies (6 listed) are FDA-registered but restricted. Category 2 peptides like BPC-157, CJC-1295, and Ipamorelin cannot be compounded under current rules.
Where Suppliers Are
Geography matters more than ever in 2026. April's Chinese API export restrictions and the FDA's Import Alert 66-80 are reshaping supply chains in real time.
North America: 137 suppliers. The U.S. peptide therapeutics market hit $80.8 billion in 2025 (10% CAGR). Eli Lilly dropped $6 billion on a Huntsville facility. Samsung Biologics bid $1.8 billion for PolyPeptide Group. CordenPharma bought AmbioPharm in South Carolina. Domestic capacity is scaling fast.
Browse US suppliers →
Europe: 67 suppliers. Roughly 40% of global peptide contract manufacturing. Germany leads with ~98 API facilities. Italy is largest by volume. France is the fastest-growing. CordenPharma committed EUR 900 million to expand its European GLP-1 platform.
Browse European suppliers →
Asia: 74 suppliers. China produces 1,600+ API varieties. WuXi STA and GenScript operate at kilogram-plus scale. But the FDA's Green List is the only safe path for GLP-1 imports, and April 2026 export rules add another layer of risk.
Browse Chinese suppliers →
Global: 32 suppliers with multinational operations across all regions.
How We Rank Them
Every supplier gets a confidence score from 0 to 99. The average is 80.6.
90+ (126 suppliers): Extensively vetted with verified documentation and clean regulatory history.
80-89 (132): Well-vetted with solid sourcing notes.
70-79 (19): Some verification gaps.
Below 50 (28): Limited or no verification. Often defunct or self-reported.
Filter by verification badges: GMP certified (82), ISO certified (29), third-party tested (162), COA available (187), manufactured in-house (156).
Browse the Full Directory
- By type: Manufacturers · CDMOs · Research Suppliers · Bulk/Wholesale · Pharmacies
- By location: USA · China · Europe · UK · India
- By capability: Custom Synthesis · Peptide APIs · Manufacturing